Linganisha mbinu

	AddiQoL: Kipimo cha Ubora wa Maisha kwa Upungufu wa Tezi za Adrenal	AGHDA: Tathmini ya Upungufu wa Homoni ya Ukuaji kwa Watu Wazima
Nyanja	Endokrinolojia	Endokrinolojia
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	2012	2000
Mwanzilishi	Adriana Evers, Jeanieke Tiemensma	Anthony Hunt, Garry Werther, Peter Wrightson
Aina	Patient self-report questionnaire	Patient self-report questionnaire
Chanzo asilia	Evers, A. C., & Tiemensma, J. (2012). AddiQoL: A disease-specific quality of life scale for patients with primary adrenal insufficiency. J Clin Endocrinol Metab, 97(10), 3501-3508.	Hunt, A. E., Werther, G. A., & Wrightson, P. (2000). The utility of AGHDA in identifying GH-deficient adults. Clin Endocrinol (Oxf), 52(3), 341-346.
Majina mbadala	Addison Quality of Life, AI-QoL	AGHDA-25
Zinazohusiana	3	3
Muhtasari	AddiQoL is a disease-specific quality of life questionnaire developed to assess the burden of primary and secondary adrenal insufficiency, encompassing physical, emotional, and social domains relevant to patients on glucocorticoid and mineralocorticoid replacement therapy. Developed by Evers and Tiemensma in 2012, it is the first formally validated instrument specifically designed for adrenal insufficiency populations.	The AGHDA is a 25-item disease-specific quality of life questionnaire designed to assess the burden of adult growth hormone (GH) deficiency. Developed by Hunt, Werther, and colleagues in 2000, it evaluates symptoms and functional impairments directly related to GH deficiency, including fatigue, reduced muscle strength, weight gain, and psychological difficulties. The instrument is widely used in endocrinology practice and clinical trials to quantify the impact of GH replacement therapy.